SCHEDULE 13G: First Light Asset Management and Mathew Arens Disclose Significant 15.17% Stake in AnaptysBio Inc.

First Light Asset Management, LLC and its managing member, Mathew P. Arens, have jointly disclosed a beneficial ownership of 15.17% of AnaptysBio Inc.'s common stock.

Summary

• First Light Asset Management, LLC and Mathew P. Arens have filed a Schedule 13G, reporting their beneficial ownership in AnaptysBio Inc.
• The reporting persons collectively beneficially own 4,653,068 shares of AnaptysBio Inc.'s common stock.
• This ownership represents 15.17% of the total outstanding common stock of AnaptysBio Inc.
• First Light Asset Management, LLC acts as an investment adviser to separately managed accounts and private funds holding these shares.
• Mathew P. Arens is deemed a beneficial owner due to his control as managing member and majority owner of First Light Asset Management, LLC.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer, except for activities solely related to nominations under Rule 14a-11.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as it indicates a significant investment by an institutional investor, suggesting confidence in the company. However, it's a factual disclosure of ownership rather than a performance report, so the sentiment is not strongly positive or negative.

Positives

• The disclosure of a significant 15.17% stake by an investment adviser and its principal may signal confidence in AnaptysBio Inc.'s long-term prospects.
• The filing indicates that the investment was made in the ordinary course of business, suggesting a strategic, rather than activist, investment intent.

Risks

• While the filing states the shares are not held for the purpose of changing or influencing control, a significant ownership stake like 15.17% could still provide the beneficial owners with substantial influence over corporate decisions, potentially diverging from the interests of other shareholders.
• The certification allows for activities solely in connection with a nomination under Rule 14a-11, indicating a potential for future engagement in director elections.

Management Comments

• First Light Asset Management, LLC and Mathew P. Arens certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of or with the effect of changing or influencing the control of AnaptysBio Inc., other than activities solely in connection with a nomination under Rule 14a-11.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by an investment firm could be viewed positively, potentially indicating institutional confidence and stability in the shareholder base. It also highlights a large block of shares under shared voting and dispositive power, which could influence future corporate actions.

Key Dates

Keywords

AnaptysBio Inc., First Light Asset Management, Mathew P. Arens, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Biotechnology, SEC Filing, Shareholder Disclosure